Management of severe malaria

Parassitologia

Volumn 41, Issue 1-3, 1999, Pages 287-294

  Warrell, D A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ancillary agents; Artemisinin derivatives; Cerebral malaria; Plasmodium falciparum; Quinine loading dose; Severe malaria; Suppository formulation

Indexed keywords

ADULT; CHILD; HUMAN; MALARIA; REVIEW;

ADULT; CHILD; HUMANS; MALARIA;

EID: 0033181624     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Boele van Hensbroek M, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, Enwere G, Forck S, Nusmeijer A, Bennett S, Greenwood B, Kwiatkowski D (1996a). A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335 69-75
2. Boele van Hensbroek M, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B (1996b) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria J Infect Dis 174 1091-1097.
3. Bonington A, Davidson RN, Winstanley PA, Pasvol G (1996). Fatal quinine cardiotoxicity in the treatment of falciparum malaria. Trans R Soc Trop Med Hyg 90: 305-307
4. Brandts CH, Ndjavé M, Graninger W, Kremsner PG (1997). Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350 704-709.
5. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG (1994) Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51 251-259.
6. Brewster DR, Kwiatkowski D, White NJ (1990) Neurological sequelae of cerebral malaria in children. Lancet 336: 1039-1043.
7. Carr RA, Molyneux ME, Mwenechanya JJ, Tembo M, Lucas SB, Taylor TE (1998). Macroscopic evidence of moderate brain swelling in paediatric cerebral malaria: an autopsy study. In: 47th Annual Meeting American Society of Tropical Medicine and Hygiene, San Juan, Puerto Rico, October 18-22, 1998. Abstract 376.
8. Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K (1996) Seizures and status epilepticus in childhood cerebral malaria. Q J Med 89: 591-597.
9. Danis M, Chandenier J, Doumbo O et al. (1996). Results obtained with i.m. artemether versus i.v. quinine in the treatment of severe malaria in a multi-centre study in Africa. Jpn J Trop Med Hyg 24: 93-96.
10. Daroff RB, Deller JJ, Castl AJ, Blocker WW (1967). Cerebral malaria J Am Med Assoc 202: 119-122.
11. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD (1983) Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci USA 80: 5075-5079
12. Di Pern G, Di Perri IG, Monteiro GB, Bonora S, Hennig C, Cassatella M, Micciolo R, Vento S, Dusi S, Bassetti D (1995) Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 171: 1317-1322.
13. English M, Muambi B, Mithwani S, Marsh K (1997). Lactic acidosis and oxygen debt in African children with severe anaemia. Q J Med 90: 563-569.
14. English M, Waruiru C, Marsh K (1996). Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg 55: 525-30
15. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA (1996). Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against Tumor Necrosis Factor α N Engl J Med 335: 311-315.
16. Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E (1992). Effect of ion chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med 327: 1473-1477
17. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert P-H (1989). Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591.
18. Hien TT, Day NP, Phu NH, Mai NT, Chau TT, Loc PP, Sinh DX, Chuong LV, Vinh H, Waller D, Peto TEA, White NJ (1996) A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335: 76-83
19. Hoffman SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, Dimpudus AJ, McKee KT, Paleologo SP, Campbell JR, Marwoto H, Laughlin L (1988). High-dose dexamethasone in quinine-treated patients with cerebral malaria. a double-blind, placebo-controlled trial. J Infect Dis 158: 325-331.
20. Holloway PA, Knox K, Bajaj N, Chapman D, White NJ, O'Brien R, Stacpoole PW, Krishna S (1995). Plasmodium berghei infection dichloroacetate improves survival in rats with lactic acidosis. Exp Parasitol 80: 624-632.
21. Jaramillo-Arango J (1950). The conquest of malaria. William Heinemann, London, UK.
22. Karbwang J, Tin T, Rimchala W, Sukontason K, Namsiripongpun V, Thanavibul A, Na-Bangchang K, Laothavorn P, Bunnag D, Harinasuta T (1995). Comparison of artemether and quinine in the treatment of severe falciparum malaria in South-East Thailand. Trans R Soc Trop Med Hyg 89: 668-671.
23. Krishna S, Supanaranond W, Pukrittayakamee S, Carter D, Supputamongkol Y, Davis TM, Holloway PA, White NJ (1994). Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment Metabolism 43: 974-981.
24. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM (1990). TNF concentration in fatal cerebral, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 336 1201-1204.
25. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE (1993). Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 86: 91-98.
26. Li G, Guo X, Jin R, Wang Z, Jian H, Li Z (1982). Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J Trad Chinese Med 2: 125-130.
27. Looareesuwan S, Phillips RE, Karbwang J, White NJ, Flegg PJ, Warrell DA (1990). Plasmodium falciparum hyperparasitaemia. use of exchange transfusion in seven patients and a review of the literature. Q J Med 75: 471-481.
28. Looareesuwan S, Sjostrom L, Krudsood S, Wilairatana P, Porter RS, Hills F, Warrell DA (1999). Polyclonal anti-Tumor Necrosis Factor-α Fab used as an ancillary treatment in severe malaria. Am J Trop Med Hyg 61: 26-33.
29. Looareesuwan S, Warrell DA, White NJ, Suntharasamai P, Chanthavanich P, Sundaravej K, Juel-Jensen BE, Bunnag D, Harinasuta T (1983). Do patients with cerebral malaria have cerebral oedema? A computed tomography study. Lancet 1: 434-437.
30. Looareesuwan S, Wilairatna P, Vannaphan S, Wanaratana V, Wenisch C, Aikawa M, Brittenham G, Graninger W, Wernsdorfer WH (1998). Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. Am J Trop Med Hyg 58: 348-353.
31. Louis FJ, Fargier JJ, Maubert B, Louis JP, Hounsinou C, Le Bras J, Touze JE (1992) Acces palustre grave de l'adulte au Cameroun: comparaison de deux protocoles therapeutiques utilisant la quinine par voie parenterale. Ann Soc Belg Méd Trop 72: 179-188
32. Marchiafava E, Bignami A (1894). On summer-autumn malarial fevers New Sydenham Society, London, UK
33. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R (1995). Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399-1404.
34. McGregor IA, Carrington SP, Cohen S (1963). Treatment of East African P. falciparum malaria with West African human gamma-globulin Trans R Soc Trop Med Hyg 57: 170-175.
35. Mehta SR, Lazar AI, Kasthuri AS (1994). Experience on loading dose-quinine therapy in cerebral malaria. J Assoc Physns India 42: 376-378.
36. Murphy S, English M, Waruiru C, Mwangi I, Amukoye E, Crawley J, Newton C, Winstanley P, Peshu N, Marsh K (1996). An open randomised trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 90: 298-301.
37. Murphy S, Mberu E, Muhia D, English M, Crawley J, Waruiru C, Lowe B, Newton CRJ, Winstanley P, Marsh K, Watkins WM (1997). The disposition of intramuscular artemether in children with cerebral malaria: a preliminary study. Trans R Soc Trop Med Hyg 91: 331-334
38. Newton CRJC, Kirkham FJ, Winstanley PA, Pasvol G, Peshu N, Warrell DA, Marsh K (1991). Intracranial pressure in African children with cerebral malaria. Lancet 337: 573-576
39. Newton CRJC, Peshu N, Kendall B, Kirkham FJ, Sowunmi A, Waruiru C, Mwangi I, Murphy SA, Marsh K (1994) Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Childhood 70: 281-287.
40. Prasad K, Haines T (1995). Dexamethasone treatment for acute bacterial meningitis how strong is the evidence for routine use? J Neurol Neurosurg Psychiatry 59: 31-37.
41. Seaton RA, Trevett AJ, Wembri JP, Nwokolo N, Naraqi S, Black J, Laurenson IF, Kevau I, Saweri A, Lalloo DG, Warrell DA (1998) Randomised comparison of intramuscular artemether and intravenous quinine in adult, Melanesien patients with severe or complicated, Plasmodium falciparum malaria in Papua New Guinea Ann Trap Med Parasitol 92: 133-139
42. Shann F (1995) Antipyretics in severe sepsis. Lancet 345: 338.
43. Singh B, Ho M, Mathai E, Looareesuwan S, Warrell DA, Hommel M (1988) Plasmodium falciparum inhibition/reversal of cytoadherence of Thai isolates to melanoma cells by local immune sera. Clin Exp Immunol 72: 145-150
44. Sinton JA, Kehar ND (1931). Changes in the amount of blood sugar in malaria Records of the Malaria Survey of India 2: 287-304.
45. Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan CA, Harman EM, Henderson GN, Jenkinson S (1992). A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 327: 1564-1569
46. Stepniewska K on behalf of the Malaria Trialists Collaborative Group (1998) Meta-analysis of artemether-quinine trials in severe malaria In: 2nd European Congress on Tropical Medicine, Sept 14-18, 1998, Liverpool, UK. Abstract 380.
47. Taylor TE, Molyneux ME, Winma JJ, Borgstein A, Goldring JD, Hommel M (1992) Intravenous immunoglobulin in the treatment of paediatric cerebral malaria Clin Exp Immunol 90: 357-362
48. Taylor TE, Wills BA, Courval JM, Molyneux ME (1998) Intramuscular artemether vs intravenous quinine an open, randomised trial in Malawian children with cerebral malaria Trap Med Int Hlth 3: 3-8
49. Thuma PE, Mabeza GF, Biemba G, Bhat GJ, McLaren CE, Moyo VM, Zulu S, Khumalo H, Mabeza P, M'Hango A, Parry D, Poltera AA, Brittenham GM, Gordeuk VR (1998). Effect of ion chelation therapy on mortality in Zambian children with cerebral malaria Trans R Soc Trop Med Hyg 92: 214-218
50. van der Torn M, Thuma PE, Mabeza GF, Biemba G, Moyo VM, McLaren CE, Brittenham GM, Gordeuk VR (1998). Loading dose of quinine in African children with cerebral malaria. Trans R Soc Trop Med Hyg 92: 325-331.
51. Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PAH, Brewster D, Greenwood BM, White NJ (1995). Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 21 577-587
52. Warrell DA, Looareesuwan S, Phillips RE, White NJ, Warrell MJ, Chapel HM, Areekul S, Tharavanij S (1986). Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am J Trop Med Hyg 35: 882-889
53. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T (1982). Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients N Engl J Med 306: 313-319
54. White NJ (1995). Optimal regimens of parenteral quinine (Correspondence). Trans R Soc Trop Med Hyg 89: 462-463
55. White NJ (1999). Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41: 301-308.
56. White NJ, Looareesuwan S, Phillips RE, Chanthavanich P, Warrell DA (1988). Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet 9(2): 64-66.
57. White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Chanthavanich P, Bunnag D, Harinasuta T (1983). Quinine loading dose in cerebral malaria Am J Trop Med Hyg 32 1-5
58. White NJ, Warrell DA, Chanthavanich P, Looareesuwan S, Warrell MJ, Krishna S, Williamson DH, Turner RC (1983) Severe hypoglycaemia and hyperinsulinaemia in falciparum malaria. N Engl J Med 309: 61-66.
59. Wiegers GJ, Reul JMHM (1998). Induction of cytokine receptors by glucacorticoids: functional and pathological significance. Trends Pharmacol Sci 19: 317-321.
60. Winstanley PA, Newton CRJC, Pasvol G, Kirkham F, Mberu E, Peshu N, Ward SA, Were JB, Warrell DA, Marsh K (1992). Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects. Br J Clin Pharmacol 33: 149-154
61. Winstanley PA, Pasvol G, Marsh K (1995) Quinine dose recommendations in childhood malaria - a reply (Correspondence) Trans R Soc Trop Med Hyg 89: 463-464.
62. World Health Organization Malaria Action Programme (1986). Severe and complicated malaria. Trans R Soc Trop Med Hyg 80, Suppl 1-50.
63. World Health Organization Division of Control of Tropical Diseases (1990) Severe and complicated malaria, 2nd edition. Trans R Soc Trop Med Hyg 84, Suppl: 1-65.
64. World Health Organization Division of Control of Tropical Diseases (1999) Severe falciparum malaria, 3rd edition. Trans R Soc Trop Med Hyg, Suppl in press
65. World Health Organization Programme for the Control of Acute Respiratory Infections (1993). The management of fever in young children with acute respiratory infections in developing countries World Health Organization, Geneva, WHO/ARI/93 30